Literature DB >> 8075868

Rapid desensitization of adrenaline- and neuropeptide Y-stimulated Ca2+ mobilization in HEL-cells.

M C Michel1.   

Abstract

1. Desensitization of Gs-coupled receptors, the beta 2-adrenoceptor for example, involves rapid and slower components but little is known regarding the existence of rapid desensitization of Gi-coupled receptors and its possible mechanisms. In HEL-cells stimulation of alpha 2A-adrenoceptors by adrenaline or Y1-like neuropeptide Y receptors by neuropeptide Y, transiently mobilizes Ca2+ from intracellular stores via a Gi-protein. We have used this model to study the existence and possible mechanisms of rapid desensitization of a Gi-mediated cellular response. 2. Following stimulation by adrenaline or neuropeptide Y Ca2+ levels returned towards baseline a few minutes after agonist addition and were refractory to a second agonist exposure demonstrating rapid desensitization. Cross-desensitization experiments with neuropeptide Y, adrenaline and moxonidine demonstrated the presence of homologous (both receptors) and heterologous desensitization (neuropeptide Y receptors only), and that the alpha 2A-adrenoceptor desensitization was not specific for phenylethylamine (adrenaline) or imidazoline agonists (moxonidine). 3. The protein kinase C activator, phorbol ester, rapidly desensitized the hormonal Ca2+ responses and inhibitors of protein kinase C enhanced the hormonal responses inconsistently. The tyrosine kinase inhibitor, herbimycin, enhanced Ca2+ mobilization by adrenaline and neuropeptide Y, whereas the protein phosphatase inhibitor, okdadaic acid, did not affect Ca2+ mobilization or its desensitization. 4. In the absence of extracellular Ca2+ the endoplasmic reticulum Ca(2+)-ATPase inhibitor, thapsigargin, reduced hormone-stimulated Ca2+ elevations, demonstrating that mobilization occurs from a thapsigargin-sensitive pool in the endoplasmic reticulum. The inositol phosphate-independent Ca2+release modulator, ryanodine, significantly enhanced adrenaline- and neuropeptide Y-stimulated Ca2+elevations. Blockade of the endoplasmic reticulum Ca2+-ATPase by thapsigargin in the presence of extracellular Ca2+ enhanced hormone-stimulated Ca2+ increases, demonstrating the importance of this enzyme for the termination of the Ca2+ signal.5. It is concluded that adrenaline and neuropeptide Y-stimulated Ca2+ mobilization in HEL-cells occurs from a thapsigargin- and ryanodine-sensitive store in the endoplasmic reticulum and desensitizes rapidly;this appears to involve multiple mechanisms including protein kinases, possibly acting on receptors, and Ca2+ release and sequestration mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8075868      PMCID: PMC1910331          DOI: 10.1111/j.1476-5381.1994.tb13101.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Lack of cross-desensitization between structurally dissimilar alpha-adrenoceptor agonists.

Authors:  R R Ruffolo; B S Turowski; P N Patil
Journal:  J Pharm Pharmacol       Date:  1977-06       Impact factor: 3.765

2.  Tyrosine phosphorylation of G protein alpha subunits by pp60c-src.

Authors:  W P Hausdorff; J A Pitcher; D K Luttrell; M E Linder; H Kurose; S J Parsons; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

3.  Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor.

Authors:  B K Kobilka; H Matsui; T S Kobilka; T L Yang-Feng; U Francke; M G Caron; R J Lefkowitz; J W Regan
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

4.  Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.

Authors:  R M McKernan; M J Howard; H J Motulsky; P A Insel
Journal:  Mol Pharmacol       Date:  1987-08       Impact factor: 4.436

5.  Alpha 2-adrenergic receptor stimulation mobilizes intracellular Ca2+ in human erythroleukemia cells.

Authors:  M C Michel; L F Brass; A Williams; G M Bokoch; V J LaMorte; H J Motulsky
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

6.  Norepinephrine and neuropeptide Y increase intracellular Ca2+ in cultured porcine aortic smooth muscle cells.

Authors:  W Erdbrügger; P Vischer; H J Bauch; M C Michel
Journal:  J Cardiovasc Pharmacol       Date:  1993-07       Impact factor: 3.105

7.  Guanine nucleotide-binding protein Go-induced coupling of neuropeptide Y receptors to Ca2+ channels in sensory neurons.

Authors:  D A Ewald; P C Sternweis; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.

Authors:  J Krause; C Eva; P H Seeburg; R Sprengel
Journal:  Mol Pharmacol       Date:  1992-05       Impact factor: 4.436

9.  Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type.

Authors:  D Larhammar; A G Blomqvist; F Yee; E Jazin; H Yoo; C Wahlested
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

10.  Neuropeptide Y mobilizes Ca2+ and inhibits adenylate cyclase in human erythroleukemia cells.

Authors:  H J Motulsky; M C Michel
Journal:  Am J Physiol       Date:  1988-12
View more
  1 in total

1.  Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.

Authors:  A Bischoff; W Erdbrügger; J Smits; M C Michel
Journal:  J Physiol       Date:  1996-09-01       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.